Foresite Capital Management VI LLC
Source: SEC Form 13F · as of Mar 2026Foresite Capital Management VI LLC holds 10 biotech & pharma companies tracked by BioSniper, totaling $226.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$226.1M
BioSniper AIPage evidence connected
Prepared research question
What matters most for ALUMIS INC. (ALMS)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ALMSALUMIS INC. | 4,247,670 | $93.6M |
| CNTACentessa Pharmaceuticals plc | 1,364,019 | $54.2M |
| DNLIDenali Therapeutics Inc. | 1,209,971 | $23.2M |
| AGIOAGIOS PHARMACEUTICALS, INC. | 525,000 | $17.8M |
| CLDXCelldex Therapeutics, Inc. | 315,913 | $10.0M |
| ATAIAtai Beckley N.V. | 2,750,000 | $9.7M |
| OKUROnKure Therapeutics, Inc. | 1,445,783 | $6.0M |
| JBIOJade Biosciences, Inc. | 320,000 | $4.5M |
| GHRSGH Research PLC | 315,492 | $4.4M |
| ZURAZura Bio Ltd | 450,000 | $2.7M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.